| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | MZK2GP0RHK |
| InChI Key | ASUGUQWIHMTFJL-QGZVFWFLSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H19F3N6O |
| Molecular Weight | 392.39 |
| AlogP | 3.28 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 95.59 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Tyrosine-protein kinase JAK3 inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase JakA family
|
- | 11-112 | - | 13 | - | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase JakB family
|
- | 11-112 | - | 13 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3039513 |
| DrugBank | DB12566 |
| EPA CompTox | DTXSID70241504 |
| FDA SRS | MZK2GP0RHK |
| Guide to Pharmacology | 8309 |
| PDB | VJK |
| PubChem | 59422203 |
| SureChEMBL | SCHEMBL2630387 |
| ZINC | ZINC000096941867 |